285 related articles for article (PubMed ID: 29888013)
1. A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge.
Hashmi H; Murray D; Greenwell J; Shaikh M; Basu S; Krem M
Case Rep Hematol; 2018; 2018():7865325. PubMed ID: 29888013
[TBL] [Abstract][Full Text] [Related]
2. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
Váradi Z; Bánusz R; Csomor J; Kállay K; Varga E; Kertész G; Csóka M
Onco Targets Ther; 2017; 10():521-526. PubMed ID: 28182116
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Kim S; Lee M; Shin HJ; Lee J; Suh YL
Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
[TBL] [Abstract][Full Text] [Related]
4. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
5. CNS Erdheim-Chester Disease: A Challenge to Diagnose.
Pan Z; Kleinschmidt-DeMasters BK
J Neuropathol Exp Neurol; 2017 Dec; 76(12):986-996. PubMed ID: 29096034
[TBL] [Abstract][Full Text] [Related]
6. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis).
Pegoraro F; Papo M; Cohen-Aubart F; Peyronel F; Lugli G; Trambusti I; Baulier G; de Menthon M; Le Scornet T; Oziol E; Ferreira-Maldent N; Hermine O; Faucher B; Koschel D; Straetmans N; Abisror N; Terrier B; Lifermann F; Razanamahery J; Allenbach Y; Keraen J; Bulifon S; Hervier B; Buccoliero A; Charlotte F; Monzani Q; Boussouar S; Shor N; Tondo A; Barete S; Idbaih A; Tazi A; Sieni E; Amoura Z; Emile JF; Vaglio A; Haroche J
EClinicalMedicine; 2024 Jul; 73():102658. PubMed ID: 38841707
[TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
[TBL] [Abstract][Full Text] [Related]
9. Erdheim-chester disease.
Kim MS; Kim CH; Choi SJ; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Ann Dermatol; 2010 Nov; 22(4):439-43. PubMed ID: 21165216
[TBL] [Abstract][Full Text] [Related]
10. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
12. Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid.
Imaizumi T; Daido H; Kato T; Yabe D
JCEM Case Rep; 2023 Mar; 1(2):luad014. PubMed ID: 37908458
[TBL] [Abstract][Full Text] [Related]
13. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
[TBL] [Abstract][Full Text] [Related]
14. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
15. Erdheim-Chester Disease: The Importance of Information Integration.
Nikonova A; Esfahani K; Chausse G; Probst S; Petrogiannis-Haliotis T; Knecht H; Gyger G
Case Rep Oncol; 2017; 10(2):613-619. PubMed ID: 28868020
[TBL] [Abstract][Full Text] [Related]
16. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
[TBL] [Abstract][Full Text] [Related]
17. Erdheim-Chester Disease with No Skeletal Bone Involvement and Massive Weight Loss.
Salama H; Kojan S; Abdulrahman S; Azzumeea F; Alhejazi A
Case Rep Hematol; 2017; 2017():3862052. PubMed ID: 29214086
[TBL] [Abstract][Full Text] [Related]
18. Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience.
Lim Y; Yoon SE; Cho J; Kim D; Jung CW
Cancer Res Treat; 2023 Jul; 55(3):1053-1057. PubMed ID: 36701845
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
[TBL] [Abstract][Full Text] [Related]
20. Erdheim-Chester Disease: Case Report with Aggressive Multisystem Manifestations and Review of the Literature.
Alotaibi S; Alhafi O; Nasr H; Eltayeb K; Elyamany G
Case Rep Oncol; 2017; 10(2):501-507. PubMed ID: 28690524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
